Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Molecular monitoring of residual disease using antigen receptor genes in childhood acute lymphoblastic leukaemia

1 Mar 2002

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Acute Lymphoblastic Leukemia research
Share to Chronic Myeloid Leukemia Treatments
Share to Lymphoma Diagnosis and Treatment

Source

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Identifiers

PMID: 11987915
DOI: 10.1053/beha.2002.0184

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Molecular monitoring of residual disease using antigen receptor genes in childhood acute lymphoblastic leukaemiaPMID 11987915Read ↗

Outcome prediction in childhood acute lymphoblastic leukaemia by molecular quantification of residual disease at the end of inductionSemantic proximity Read ↗

Advances in the immunological monitoring of childhood acute lymphoblastic leukaemiaSemantic proximity Read ↗

Immunoglobulin and T cell receptor gene rearrangement patterns in acute lymphoblastic leukemia are less mature in adults than in children: implications for selection of PCR targets for detection of minimal residual diseaseSemantic proximity Read ↗

Detection of residual leukemic cells in adult acute lymphoblastic leukemia by analysis of gene rearrangements and correlation with early relapses.Semantic proximity Read ↗

Status of minimal residual disease testing in childhood haematological malignanciesSemantic proximity Read ↗

Gene expression shift towards normal B cells, decreased proliferative capacity and distinct surface receptors characterize leukemic blasts persisting during induction therapy in childhood acute lymphoblastic leukemiaSemantic proximity Read ↗

Detection of minimal residual disease in pediatric acute lymphoblastic leukemiaSemantic proximity Read ↗

Molecular evaluation of residual disease as a predictor of relapse in acute promyelocytic leukaemiaSemantic proximity Read ↗

Digital PCR for Minimal Residual Disease Quantitation Using Immunoglobulin/T-Cell Receptor Gene Rearrangements in Acute Lymphoblastic LeukemiaSemantic proximity Read ↗

Genetic mechanisms of target antigen loss in CAR19 therapy of acute lymphoblastic leukemiaSemantic proximity Read ↗

Tandem application of flow cytometry and polymerase chain reaction for comprehensive detection of minimal residual disease in childhood acute lymphoblastic leukemiaSemantic proximity Read ↗

Rearranged T-cell receptor beta genes represent powerful targets for quantification of minimal residual disease in childhood and adult T-cell acute lymphoblastic leukemiaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.